In addition, as shown in Fig. 4B–E, TM4SF1 overexpression partially reversed the effect of B7-H3 knockdown on increased percentages of SA-β-gal- and SAHF-positive cells in CRC cells treated with low-dose DOX (Fig. 4B–E). This evidence concerns the gene TM4SF1 and colorectal carcinoma.